These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 29315063)
21. Diagnostic performances of [18F]fluorocholine positron emission tomography in brain tumors. Sollini M; Sghedoni R; Erba PA; Cavuto S; Froio A; De Berti G; Pisanello A; Fraternali A; Iori M; Iaccarino C; Iori M; Asti M; Filice A; Versari A Q J Nucl Med Mol Imaging; 2018 Jun; 62(2):209-219. PubMed ID: 26329494 [TBL] [Abstract][Full Text] [Related]
22. Prospective evaluation of [ Schwarzenböck SM; Eiber M; Kundt G; Retz M; Sakretz M; Kurth J; Treiber U; Nawroth R; Rummeny EJ; Gschwend JE; Schwaiger M; Thalgott M; Krause BJ Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2105-2113. PubMed ID: 27317482 [TBL] [Abstract][Full Text] [Related]
23. Significant increase in detection of prostate cancer recurrence following radical prostatectomy with an early imaging acquisition protocol with ¹⁸F-fluorocholine positron emission tomography/computed tomography. Simone G; Di Pierro GB; Papalia R; Sciuto R; Rea S; Ferriero M; Guaglianone S; Maini CL; Gallucci M World J Urol; 2015 Oct; 33(10):1511-8. PubMed ID: 25577130 [TBL] [Abstract][Full Text] [Related]
25. Feasibility of Preoperative FDG PET/CT Total Hepatic Glycolysis in the Remnant Liver for the Prediction of Postoperative Liver Function. Cho A; Chung YE; Choi JS; Kim KS; Choi GH; Park YN; Kim MJ AJR Am J Roentgenol; 2017 Mar; 208(3):624-631. PubMed ID: 28026972 [TBL] [Abstract][Full Text] [Related]
26. Imaging Intraplaque Inflammation in Carotid Atherosclerosis With 18F-Fluorocholine Positron Emission Tomography-Computed Tomography: Prospective Study on Vulnerable Atheroma With Immunohistochemical Validation. Vöö S; Kwee RM; Sluimer JC; Schreuder FH; Wierts R; Bauwens M; Heeneman S; Cleutjens JP; van Oostenbrugge RJ; Daemen JW; Daemen MJ; Mottaghy FM; Kooi ME Circ Cardiovasc Imaging; 2016 May; 9(5):. PubMed ID: 27162131 [TBL] [Abstract][Full Text] [Related]
27. Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy. How Kit N; Dugué AE; Sevin E; Allouache N; Lesaunier F; Joly F; Aide N Nucl Med Commun; 2016 Apr; 37(4):348-55. PubMed ID: 26642435 [TBL] [Abstract][Full Text] [Related]
28. Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma. Kobayashi T; Aikata H; Honda F; Nakano N; Nakamura Y; Hatooka M; Morio K; Morio R; Fukuhara T; Masaki K; Nagaoki Y; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Ohdan H; Awai K; Chayama K J Comput Assist Tomogr; 2016; 40(4):524-30. PubMed ID: 26966955 [TBL] [Abstract][Full Text] [Related]
30. [PET/CT and biochemical recurrence of prostate adenocarcinoma: Added value of Gauthé M; Belissant O; Girard A; Zhang Yin J; Ohnona J; Cottereau AS; Nataf V; Balogova S; Pontvert D; Lebret T; Guillonneau B; Cussenot O; Talbot JN Prog Urol; 2017; 27(8-9):474-481. PubMed ID: 28576423 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma. Castilla-Lièvre MA; Franco D; Gervais P; Kuhnast B; Agostini H; Marthey L; Désarnaud S; Helal BO Eur J Nucl Med Mol Imaging; 2016 May; 43(5):852-859. PubMed ID: 26577938 [TBL] [Abstract][Full Text] [Related]
32. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560 [TBL] [Abstract][Full Text] [Related]
33. Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters. Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z AJR Am J Roentgenol; 2018 Dec; 211(6):1354-1360. PubMed ID: 30300005 [TBL] [Abstract][Full Text] [Related]
34. The Added Diagnostic Value of Addeo P; Poncet G; Goichot B; Leclerc L; Brigand C; Mutter D; Romain B; Namer IJ; Bachellier P; Imperiale A J Gastrointest Surg; 2018 Apr; 22(4):722-730. PubMed ID: 29235002 [TBL] [Abstract][Full Text] [Related]
35. How we read FCH-PET/CT for prostate cancer. Beauregard JM; Beaulieu A Cancer Imaging; 2016 Dec; 16(1):41. PubMed ID: 27923396 [TBL] [Abstract][Full Text] [Related]
36. Imaging of Prostate Cancer Using Hodolič M PET Clin; 2017 Apr; 12(2):173-184. PubMed ID: 28267451 [No Abstract] [Full Text] [Related]
38. Preoperative Assessment of Pancreatic Cancer with FDG PET/MR Imaging versus FDG PET/CT Plus Contrast-enhanced Multidetector CT: A Prospective Preliminary Study. Joo I; Lee JM; Lee DH; Lee ES; Paeng JC; Lee SJ; Jang JY; Kim SW; Ryu JK; Lee KB Radiology; 2017 Jan; 282(1):149-159. PubMed ID: 27556273 [TBL] [Abstract][Full Text] [Related]
39. Development of a thin layer chromatography method for plasma correction of [ Villar M; Valiente M; Toscano M; Galmés M; González C; Ortiz M; Vega F; Oporto M; Bibiloni P; Chinchilla JL; Molina J; Ríos Á; Peña C; Rubí S Nucl Med Biol; 2019; 74-75():34-40. PubMed ID: 31473490 [TBL] [Abstract][Full Text] [Related]
40. Dual-Time-Point Broos WAM; Wondergem M; van der Zant FM; Knol RJJ J Nucl Med; 2019 Nov; 60(11):1605-1610. PubMed ID: 30877179 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]